Abbott Launches Pivotal Trial of Cephea Mitral Valve
ABBOTT PARK, Illinois, October 29, 2026 Abbott has announced the initiation of the pivotal CROWN-MV clinical trial to evaluate...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
ABBOTT PARK, Illinois, October 29, 2026 Abbott has announced the initiation of the pivotal CROWN-MV clinical trial to evaluate...
Atlanta, Georgia, USA, October 27, 2026 Nyra Medical, Inc., a clinical-stage medical technology company developing transcatheter treatments for heart...
San Jose, California, September 9, 2026 Emboline has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its...
FLAGSTAFF, Ariz., May 11, 2026 Corvention announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance...
MINNEAPOLIS & BRISBANE, May 13, 2025—Anteris Technologies Global Corp. announced its first-quarter 2025 results, revealing significant progress across clinical...
